Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor in CKD Patients with Type 2 Diabetes and Albuminuria
NCT01847092Phase 2Completed
- Sponsor
- Ardelyx
- Start
- May 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenapanor in chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), sponsored by Ardelyx. Started May 2013; status: completed.
02
Drugs
tenapanor
03
Conditions
chronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01847092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847092.